Search Results - "Niebla, A"

Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage by Navarro Matilla, B, Ortiz Romero, P L, Pujol Vallverdú, R M, Combalia Escudero, A, Zapata Paz, I, González Barca, E, Muniesa Montserrat, C, Morillo Andújar, M, Pérez Ferriols, A, Román Curto, C, Fernández de Misa Cabrera, R, Hospital Gil, M, Marín Niebla, A, Rios Rull, P J, de la Cruz Vicente, F, Izu Belloso, R M, Martín García-Sancho, A, Parera Amer, M E, Córdoba Mascuñano, R, Ramón Quiles, M D, Saus Carreres, A, Del Campo García, R, Machan, S, Viguera Ester, P, Blanco Garnelo, J

“…The cost of treating cutaneous T-cell lymphoma (CTCL) in Spain is unknown. With the advent of new treatments, it is more important than ever to gain an…”
Get full text

[Translated article] Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage by Navarro Matilla, B., Ortiz Romero, P.L., Pujol Vallverdú, R.M., Combalia Escudero, A., Zapata Paz, I., González Barca, E., Muniesa Montserrat, C., Morillo Andújar, M., Pérez Ferriols, A., Román Curto, C., Fernández de Misa Cabrera, R., Hospital Gil, M., Marín Niebla, A., Rios Rull, P.J., de la Cruz Vicente, F., Izu Belloso, R.M., Martín García-Sancho, A., Parera Amer, M.E., Córdoba Mascuñano, R., Ramón Quiles, M.D., Saus Carreres, A., del Campo García, R., Machan, S., Viguera Ester, P., Blanco Garnelo, J.

“…[Display omitted] The cost of treating cutaneous T-cell lymphoma (CTCL) in Spain is unknown. With the advent of new treatments, it is more important than ever…”
Get full text

P1588: A SINGLE CENTER COMPARATIVE CLINICAL ANALYSIS OF THE SARS‐COV‐2 INFECTION BEFORE AND AFTER VACCINATION IN PATIENTS DIAGNOSED WITH HEMATOLOGIC MALIGNANCIES by Jiménez, M., Novoa, S., Fernandez‐Naval, C., Navarro, V., Andrés, C., Martínez‐Gallo, M., Antón, A., Fox, L., Roldán, E., Cabirta, A., Gironella, M., Orti, G., Barba, P., Medina, D., Peralta, S., Pujadas, G., Hernández, C., Pages, C., Pumarola, T., Valentin, M., Marín‐Niebla, A., Valcárcel, D., Hernández, M., Ruiz‐Camps, I., Crespo, M., Esperalba, J., Bosch, F., Abrisqueta, P.

Get full text

AFM13 IN PATIENTS WITH CD30 POSITIVE RELAPSED OR REFRACTORY (R/R) PERIPHERAL T CELL LYMPHOMA (PTCL): RESULTS FROM THE PHASE 2 REDIRECT STUDY by Kim, W. S., Shortt, J., Zinzani, P. L., Mikhaylova, N., Marin‐Niebla, A., Radeski, D., Ribrag, V., Domenech, E. Domingo, Sawas, A., Alexis, K., Emig, M., Garcia, L., Overesch, A., Pietzko, K., Horwitz, S.

Get full text

Impact of COVID‐19 infection on bispecific antibodies treatment in patients diagnosed with B‐cell lymphoproliferative disorders by Serna, A., Iraola‐Truchuelo, J., Jiménez, M., Cabirta, A., Albasanz, A., Ruiz‐Camps, I., Andrés, C., Antón, A., Esperalba, J., García, T., Carpio, C., Crespo, M., Bobillo, S., Iacoboni, G., Marín‐Niebla, A., Bosch, F., Abrisqueta, P.

Get full text

A phase 2 study of zilovertamab vedotin as monotherapy or in combination in patients (pts) with aggressive and indolent B‐cell malignancies: waveLINE‐006 by Zinzani, P. L., Mayer, J., Benjamini, O., Berkovits, A., Glimelius, I., Stevens, D., Chaudhry, A., Demir, A. M., Sanz, R. G., Kim, W. S., Li, F., Halka, J., Marin‐Niebla, A., Ozcan, M., Paszkiewicz‐Kozik, E., Santoro, A., Ren, Y., Ogbu, U., Marinello, P., Jurczak, W.

Get full text

Outcomes of younger patients with mantle‐cell lymphoma experiencing late relapse (>24 months): the LATE‐POD study by Visco, C., Malinverni, C., Florea, E., Glimelius, I., Mirandola, M., Ekström‐Smedby, K., Tisi, M. C., Giné, E., Albertsson‐Lindblad, A., Niebla, A. Marin, Di Rocco, A., Moita, F., Sciarra, R., Bašić‐Kinda, S., Hess, G., Ohler, A., Eskelund, C., Re, A., Ferrarini, I., Kolstad, A., Räty, R., Quaglia, F. M., Bernardelli, A., Eyre, T. A., Scapinello, G., Stefani, P. M., Morello, L., Nassi, L., Hohaus, S., Ragaini, S., Zilioli, V. R., Bruna, R., Cocito, F., Arcari, A., Jerkeman, M.

Get full text

FIVE‐YEAR UPDATE OF THE FIRST‐LINE IMCL‐2015 GELTAMO STUDY. PROLONGED MOLECULAR AND CLINICAL RESPONSES WERE OBSERVED AFTER MRD‐DRIVEN IBRUTINIB DISCONTINUATION by Giné, E., Medina‐Herrera, A., Cruz, F. de la, Ubieto, A. Jiménez, Jiménez, J. López, García‐ Sancho, A. Martín, Terol, M J., Barca, E. González, Casanova, M., Fuente, A. de la, Niebla, A. Marín, Muntañola, A., López, T. J. González, Aymerich, M., Setoain, X., Cortés‐Romera, M., Rotger, A., Rodríguez, S., López, C., Nadeu, F., Beà, S., Campo, E., Sanz, R. García, Guillermo, A. López

Get full text

High Rate of Long-Term Survival for High-Risk Lymphoma Patients Treated With Hematopoietic Stem Cell Transplantation as Consolidation or Salvage Therapy by Espigado, I, Ríos, E, Marín-Niebla, A, Carmona, M, Parody, R, Pérez-Hurtado, J.M, Márquez, F.J, Urbano-Ispizua, A

“…Abstract Patients with high-relapse-risk lymphomas or those relapsing after initial therapy have a limited probability of cure with conventional treatment…”
Get full text

EFFICACY AND SAFETY OF IBRUTINIB IN COMBINATION WITH RITUXIMAB AS FRONTLINE TREATMENT FOR INDOLENT CLINICAL FORMS OF MANTLE CELL LYMPHOMA. RESULTS OF THE GELTAMO IMCL‐2015 STUDY by Giné, E., De la Cruz, F., Ubieto, A. Jiménez, Jiménez, J. López, García‐Sancho, A. Martín, Terol, M. J., González‐Barca, E., Casanova, M., De la Fuente Burguera, A., Niebla, A. Marín, Prat, A. Muntanola, González‐López, T. J., Aymerich, M., Setoain, X., Cortés‐Romera, M., Rotger, A., Medina, A., García‐Sanz, R., Campo, E., López‐Guillermo, A.

Get full text

Efavirenz trough levels are not associated with virological failure throughout therapy with 800 mg daily and a rifampicin-containing antituberculosis regimen by Lopez-Cortes, Luis F., Ruiz-Valderas, Rosa, Ruiz-Morales, Josefa, Leon, Eva, Campos, Antonio Vergara de, Marin-Niebla, Ana, Marquez-Solero, Manuel, Lozano, Fernando, Valiente, Rebeca

“…Objectives: To assess the safety and efficacy of efavirenz 800 mg daily in HIV-infected patients with tuberculosis receiving a rifampicin-containing regimen…”
Get full text

OUTCOMES IN FIRST RELAPSED‐REFRACTORY YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA: RESULTS FROM THE MANTLE‐FIRST STUDY by Visco, C., Di Rocco, A., Tisi, M.C., Morello, L., Evangelista, A., Zilioli, V.R., Rusconi, C., Hohaus, S., Sciarra, R., Re, A., Tecchio, C., Chiappella, A., Marin‐Niebla, A., McCulloch, R., Gini, G., Perrone, T., Nassi, L., Pennese, E., Stefani, P.M., Cox, M.C., Bozzoli, V., Fabbri, A., Polli, V., Ferrero, S., De Celis, I.A., Sica, A., Arcaini, L., Balzarotti, M., Rule, S., Vitolo, U.

Get full text

TIPIFARNIB IN RELAPSED OR REFRACTORY ANGIOIMMUNOBLASTIC T‐CELL LYMPHOMA (AITL) AND CXCL12+ PERIPHERAL T‐CELL LYMPHOMA (PTCL): PRELIMINARY RESULTS FROM A PHASE 2 STUDY by Witzig, T., Sokol, L., Kim, W., Foss, F., Jacobsen, E., Cruz Vincente, F., Caballero, D., Advani, R., Roncero Vidal, J.M., Marin‐Niebla, A., Rodriguez Izquierdo, A., Ona Navarrete, R., Terol, M.J., Domingo‐Domenech, E., Rodriguez, M., Piris, M.A., Bolognese, J., Janes, M.R., Burrows, F., Kessler, L., Mishra, V., Curry, R., Kurman, M., Scholz, C., Gualberto, A.

Get full text

Influence of treatment and immunological recovery on tuberculosis relapses in HIV-infected patients by LOPEZ-CORTES, L. F, MANN-NIEBLA, A, LOPEZ-CORTES, L. E, VILLANEGO, I, RODRIGUEZ-DIEZ, M, PASCUAL-CARRASCO, R

“…SETTING: Studies on tuberculosis (TB) relapse in HIV-infected patients show contradictory results regarding the optimal duration of treatment.OBJECTIVE: To…”
Get full text

Aortic Homograft for Pulmonary Artery Augmentation in Single Lung Transplantation by Rueda, Pablo, Morales, Jose, Guzman, Enrique, Tellez, Jose L., Niebla, Benito A., Avalos, Alejandro, Patiño, Hilda

“…We present a case of unilateral lung transplantation in which a segment of the donor’s descending aorta was used as a homograft for pulmonary artery…”
Get full text

Hemopoietic Stem Cell Transplantation in Childhood: Reduction in Mortality and Improvement of Survival Over the Years by Espigado, I., Marı́n-Niebla, A., Pérez-Hurtado, J.M., Rı́os, E., Carmona, M., Plaza, E., Vaquero, A., Campo, T., Pérez de Soto, I., Martino, M.L., Parody, R., Rodrı́guez-Fernández, J.M.

“…Stem cell transplantation (SCT) is an effective treatment for life-threatening hematologic and nonhematologic pediatric diseases. Reducing transplant-related…”
Get full text

A response surface methodology approach to optimise pretreatments to prevent enzymatic browning in potato (Solanum tuberosum L) cubes by Reyes-Moreno, C, Parra-Inzunza, M A, Milán-Carrillo, J, Zazueta-Niebla, J A

“…The objective of this work was to find the best combinations of ascorbic acid concentration/soaking time (Pretreatment 1), 4‐hexylresorcinol…”
Get full text

Phase I/II trials of autologous peripheral blood stem cell transplantation in autoimmune diseases resistant to conventional therapy: preliminary results from the Spanish experience by Espigado, I, Marı́n-Niebla, A, Rovira, M, Juliá, A, Rodrı́guez, J.M, Altés, A, Arranz, R, Bargay, J, Diez, J.L, Forés, R, Morales, A, Graus, F, Messague, I, Hernández, J.C, Parody, R, Richard, C, Ferrá, C, Garcı́a, A, Carreras, E

Get full text

Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study by Malinverni, Chiara, Bernardelli, Andrea, Glimelius, Ingrid, Mirandola, Massimo, Smedby, Karin E., Tisi, Maria Chiara, Giné, Eva, Albertsson-Lindblad, Alexandra, Marin-Niebla, Ana, Di Rocco, Alice, Moita, Filipa, Sciarra, Roberta, Bašić-Kinda, Sandra, Hess, Georg, Ohler, Anke, Eskelund, Christian W., Re, Alessandro, Ferrarini, Isacco, Kolstad, Arne, Räty, Riikka, Quaglia, Francesca Maria, Eyre, Toby A., Scapinello, Greta, Stefani, Piero Maria, Morello, Lucia, Nassi, Luca, Hohaus, Stefan, Ragaini, Simone, Zilioli, Vittorio Ruggero, Bruna, Riccardo, Cocito, Federica, Arcari, Annalisa, Jerkeman, Mats, Visco, Carlo

“…•Patients with MCL experiencing late relapse benefit from BTK-inhibitors over chemoimmunotherapies.•Overall, chemoimmunotherapies as second-line treatment are…”
Get full text

Hemopoietic stem cell transplantation in refractory rheumatoid arthritis is not a contraindication for reconstructive surgery by ESPIGADO, I, GARCIA, A, RODRIGUEZ, J. M, VALENZUELA, A, MARIN-NIEBLA, A, CARMONA, M

“…Hemopoietic stem cell transplantation (HCST) is an experimental therapy that may produce prolonged remissions in patients with rheumatoid arthritis (RA)…”
Get full text